Concepedia
Statistics
Publications
6
Citations
104
H-Index
Active since
2020
Affiliations
Sichuan University(Current)
State Key Laboratory of Biotherapy
West China Hospital of Sichuan University
West China Second University Hospital of Sichuan University
Sichuan Cancer Hospital
Kun Tian is an author at Sichuan University specializing in cost-effectiveness analysis, cost-effectiveness, and oncology.
Publications per year
2020–2023
Durvalumab vs placebo consolidation therapy after chemoradiotherapy in stage III non-small-cell lung cancer: An updated PACIFIC trial-based cost-effectiveness analysis
Jiaqi Han, Kun Tian, Jianping Yang et al. · Lung Cancer · 2020 · 29 citations
Medicine, Oncology, Pharmacoeconomics +15
Immune checkpoint inhibition in first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: A CAPTAIN-1st and JUPITER-02 trial-based cost-effectiveness analysis
Kun Tian, Jiaqi Han, Zhu Wang et al. · Oral Oncology · 2022 · 20 citations
Life Sciences, Immunology, Oncology +17
<p>Cost-Effectiveness of Ribociclib for Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer</p>
Jianping Yang, Jiaqi Han, Maolang Tian et al. · Cancer Management and Research · 2020 · 17 citations · Full text
Pharmacy, Oncology, Pharmacoeconomics +17
First‐line immunotherapy combinations for recurrent or metastatic nasopharyngeal carcinoma: An updated network meta‐analysis and <scp>cost‐effectiveness</scp> analysis
Jiaqi Han, Ni Zeng, Kun Tian et al. · Head & Neck · 2023 · 15 citations
Cost-effectiveness analysis of metronomic capecitabine as adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma
Longjiang She, Kun Tian, Jiaqi Han et al. · Frontiers in Oncology · 2022 · 12 citations · Full text
1–5 of 6